For AI assistants & researchers — machine-readable summary of this page
What this page is: Delvantic's full research page for FactSet Research Systems Inc. (FDS) — AI-driven forensic equity research: mechanical valuation models (DCF, EPV, anchored-PE, scenario) plus three independent AI lenses (Quality / Value / Sentiment). Everything below is rendered server-side; you are not missing content that requires JavaScript. All scores are predictions and research opinions, not financial advice.
Our current read (analysis of 2026-09-04): Designation Watch · Gem Score +12 (−100…+100 Quality+Value blend) · Quality 76 · Value -30 · Sentiment 4 (timing only, not weighted)
Page map (sections in order; each card carries a stable
reference-name attribute you can cite):
profile-header/price-overview— company profile, live quote, market capextended-analysis— the core: three AI lens reads with findings, scores, and the analyst memofuture-predictions— our forward price-band predictionsmarket-narrative/ai-findings/gpt-critique— narrative context, cross-model findings, and an adversarial critique of our own analysis (near the end of the document)- Members-only sections (render as login gates for anonymous readers):
price-history,income-trend,key-metrics,financials(statement tables),insider-trading. The analysis above is public; the raw data tables require a free account.
More for machine readers: site briefing at
/llms.txt ·
any ticker resolves at delvantic.com/stock/TICKER ·
raw inputs are public-company filings and market data (via licensed data feeds);
every model, score, lens read, and prediction on this page is Delvantic's own analysis.
FactSet Research Systems Inc.
FDS NYSEFactSet Research Systems Inc. is a financial technology and data company that provides integrated financial information, analytics, and workflow solutions to institutional clients worldwide. The company offers a digital platform that aggregates and connects market data, company financials, estimates, ownership, and alternative data, delivering them through customizable workstations, APIs, and data feeds. FactSet serves asset managers, wealth managers, investment banks, private equity firms, and corporate clients, helping them with research, portfolio analytics, risk management, trading workflows, and regulatory and reporting requirements. Its solutions include portfolio and risk analytics, quantitative research tools, content and data management, and AI-powered analytics embedded directly into client workflows. FactSet also operates enterprise solutions that integrate with clients’ internal systems, enabling firm-wide data consistency and decision support across front, middle, and back-office functions. Founded in 1978 and headquartered in Norwalk, Connecticut, FactSet plays a central role in supporting data-driven decision-making across global capital markets.
Price Overview
Price History (1 Year)
Revenue & Net Income Trend
| Period | Revenue | Net Income | Net Margin | YoY/QoQ |
|---|
Key Metrics
EPS (Diluted): 15.55
Total Equity: $2.19B
Shares: 38,394,855
Total Debt: $1.37B
Cash: $337.65M
EBITDA: $965.96M
Total Debt: $1.37B
Cash: $337.65M
Revenue: $2.32B
Revenue: $2.32B
Revenue: $2.32B
Total Equity: $2.19B
Tax Rate: 17.2%
Equity: $2.19B
Total Debt: $1.37B
Cash: $337.65M
Current Liabilities: $521.31M
Long-Term Debt: $1.37B
Total Debt: $1.37B
Total Equity: $2.19B
Shares: 38,394,855
Shares: 38,394,855
CapEx: -$108.81M
Shares: 38,394,855
Stock Price: $283.49
Net Income: $597.04M
Industry Benchmarks
Income Statement (Annual)
Last updated: Aug 15, 2026 10:46am (20d ago)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $1.6B | $1.8B | $2.1B | $2.2B | $2.3B |
| Cost of Revenue | $786.4M | $871.1M | $973.2M | $1.0B | $1.1B |
| Gross Profit | $805.0M | $972.8M | $1.1B | $1.2B | $1.2B |
| Operating Expenses | $331.0M | $433.0M | $457.1M | $485.1M | $475.7M |
| Operating Income | $474.0M | $539.8M | $655.2M | $706.0M | $748.3M |
| Net Income | $399.6M | $396.9M | $468.2M | $537.1M | $597.0M |
| EBITDA | $583.1M | $673.3M | $813.9M | $877.6M | $966.0M |
| EPS | $10.62 | $10.43 | $12.26 | $14.11 | $15.74 |
| EPS (Diluted) | $10.36 | $10.25 | $12.04 | $13.91 | $15.55 |
Balance Sheet (Annual)
Last updated: Aug 15, 2026 10:26am (20d ago)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | $681.9M | $503.3M | $425.4M | $423.0M | $337.7M |
| Total Current Assets | $933.6M | $870.3M | $770.1M | $835.8M | $729.8M |
| Total Assets | $2.2B | $4.0B | $4.0B | $4.1B | $4.3B |
| Current Liabilities | $315.7M | $438.3M | $484.3M | $667.1M | $521.3M |
| Long-Term Debt | $574.5M | $2.0B | $1.6B | $1.2B | $1.4B |
| Total Liabilities | $1.2B | $2.7B | $2.3B | $2.1B | $2.1B |
| Total Equity | $1.0B | $1.3B | $1.6B | $1.9B | $2.2B |
| Retained Earnings | $912.5M | $1.2B | $1.5B | $1.9B | $2.3B |
Cash Flow (Annual)
Last updated: Aug 15, 2026 10:46am (20d ago)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | $555.2M | $538.3M | $645.6M | $700.3M | $726.3M |
| Capital Expenditure | -$61.3M | -$51.2M | -$60.8M | -$85.7M | -$108.8M |
| Free Cash Flow | $493.9M | $487.1M | $584.8M | $614.7M | $617.5M |
| Acquisitions (net) | -$58.1M | -$2.0B | -$23.6M | $0 | -$348.3M |
| Net Debt Issued / (Repaid) | $0 | $1.4B | -$375.0M | -$250.0M | -$1.6M |
| Dividends Paid | -$117.9M | -$125.9M | -$138.6M | -$150.7M | -$160.0M |
| Stock Buybacks | -$264.7M | -$18.6M | -$176.7M | -$235.2M | -$300.5M |
| Net Change in Cash | $96.3M | -$178.6M | -$77.8M | -$2.5M | -$71.3M |
Growth Trends (YoY %)
Last updated: Aug 15, 2026 10:46am (20d ago)| Metric | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue Growth | +15.9% | +13.1% | +5.6% | +5.4% |
| Gross Profit Growth | +20.8% | +14.3% | +7.1% | +2.8% |
| Operating Income Growth | +13.9% | +21.4% | +7.8% | +6.0% |
| Net Income Growth | -0.7% | +18.0% | +14.7% | +11.2% |
| EBITDA Growth | +15.5% | +20.9% | +7.8% | +10.1% |
Dividend History (Last 20)
Last updated: Aug 15, 2026 10:47am (20d ago)| Date | Dividend | Declaration | Record | Payment |
|---|---|---|---|---|
| 2026-05-29 | $1.16 | — | — | — |
| 2026-02-27 | $1.10 | — | — | — |
| 2025-11-28 | $1.10 | — | — | — |
| 2025-08-29 | $1.10 | — | — | — |
| 2025-05-30 | $1.10 | — | — | — |
| 2025-02-28 | $1.04 | — | — | — |
| 2024-11-29 | $1.04 | — | — | — |
| 2024-08-30 | $1.04 | — | — | — |
| 2024-05-31 | $1.04 | — | — | — |
| 2024-02-28 | $0.98 | — | — | — |
| 2023-11-29 | $0.98 | — | — | — |
| 2023-08-30 | $0.98 | — | — | — |
| 2023-05-30 | $0.98 | — | — | — |
| 2023-02-27 | $0.89 | — | — | — |
| 2022-11-29 | $0.89 | — | — | — |
| 2022-08-30 | $0.89 | — | — | — |
| 2022-05-27 | $0.89 | — | — | — |
| 2022-02-25 | $0.82 | — | — | — |
| 2021-11-29 | $0.82 | — | — | — |
| 2021-08-30 | $0.82 | — | — | — |
Deep Analysis
Risk : Reward — upside vs downside from this company's own quarters
Not computed yetNarrative Economics
market-narrative step).
Growth Outlook
Analyzed 2026-08-17 16:35The question every valuation on this page silently assumes: is this company likely to grow? Judged forward — the business, its category, the world — against what's already printed.
Claude Reading
Looking at the raw quarterly tape first: revenue went $562.2M → $568.7M → $570.7M → $585.5M → $596.9M → $607.6M → $611.0M → $622.9M. That's clean sequential growth, but the YoY rates tell the real story: Q1FY26 (Nov'25) was +6.8%, Q2 +7.1%, Q3 +7.4%, and Q4 (May'26) at $622.9M vs $585.5M is +6.4%. Growth is stabilizing in the mid-6s, not decelerating meaningfully. What IS decelerating — sharply — is margin. Net margin went from 26.4% (Nov'24) to 25.7% → 25.4% → 25.1% → 21.8% → 20.3%. That's a 610bp compression in two quarters. Net income in the latest quarter ($126.7M) is actually *below* the year-ago quarter ($148.5M) — earnings YoY is negative ~15%, not the +11.2% the momentum table cites (which is stale, using older comps). This is the single most important fact in the file and no prior model flags it explicitly.
So what's happening? Revenue keeps growing ~6%, but incremental margins have gone sharply negative. Either FactSet is investing heavily (AI buildout, likely) or facing genuine cost pressure / pricing weakness on renewals. Op margin at the annual level was 32.2% for FY25; the recent quarterly net margins imply operating margin has fallen into the mid-20s. The narrative layer's "anchored compounder at 10% discount to DCF" assumes stable margins — that assumption is currently being violated in real time. The synthesis composite fair value of $310 and signal-adjusted $316 (+11.6% upside) is built on trailing metrics that don't reflect the margin cliff. If I re-run a rough earnings power on annualized recent quarterly NI (~$520M vs the trailing $597M), the P/E on run-rate is closer to 19.4x, not 18.2x, and if margins keep sliding it's 21-22x forward — no longer cheap for a 6% grower.
The Market Forces model ("structural decline, margin expansion masks share loss") looks directionally right but got the margin direction wrong — margins are now *contracting*, not expanding. The thesis evaluator's -4 score and "growth upside capped" framing seems closer to reality than the synthesis's "slight upside." Pre-flight's claim of "consistent margins above 50%" is gross margin only; the operating margin trajectory is what matters and it's rolling over. A contrarian bull would argue: (a) the margin compression is discretionary AI investment that will pay off in ARR acceleration in FY27, (b) $617M FCF on a $10B market cap is a 6.1% FCF yield, respectable for durable subscription revenue, (c) debt/equity 0.63 and ROIC 19% remain healthy, and (d) the stock is already 27% off its 52w high, so bad news is partly priced. That's a coherent case — but it requires believing management is spending wisely on AI, which is unverified.
I dissent partially from the synthesis "+11.6% upside" verdict. The composite is anchored to trailing fundamentals that have visibly deteriorated in the last two prints. Fair value on run-rate earnings and a fair 18-19x multiple for a 6% grower with margin uncertainty is closer to $270-285 — roughly where it trades. I'd call this fairly valued, not undervalued, with negative skew until Q1FY27 shows whether the margin drop stabilizes. The bull case at $310+ requires margins to recover to 24%+ by mid-FY27; the bear case at $230 requires margins to keep sliding toward 18%. Balance sheet is fine, FCF conversion is intact ($617M FCF vs $597M NI = 103%, contradicting Market Forces' "earnings-to-cash flow divergence" claim — that signal looks wrong). I'd wait for the next print. No position here; if it drops to $250 on another weak margin quarter, that becomes an interesting entry because the franchise durability is real even if growth is capped.
GPT Reading
What stands out is not a broken business but a very steady one that the data-driven summaries occasionally overdramatize. Revenue has climbed from $1.59B in 2021 to $2.32B in 2025, a 9.9% four-year CAGR off the annual figures, while net income rose from $399.6M to $597.0M, with 2025 net margin at 25.7%. That is not “structural decline”; it is a mature subscription-like franchise still compounding at a respectable mid-single to high-single rate with excellent incremental economics. The quarterly cadence is also better than the more bearish labels imply: the last four reported quarters were $568.7M, $570.7M, $585.5M, and $596.9M in 2025, then $607.6M, $611.0M, and $622.9M in the current year-to-date. That is slow, yes, but consistently upward. On a trailing basis from the quarterly data, revenue is about $2.44B and net income about $566.0M, implying some recent margin slippage but still a very healthy ~23% trailing net margin.
The key issue is valuation versus growth, and here I think the stock is closer to modestly undervalued than merely fair. At $10.08B market cap and $617.5M of free cash flow in the latest fiscal year, the equity trades around 16.3x FCF, while the stated P/E is 18.2x and EV/EBITDA 12.2x. For a business with 52.7% gross margin, 32.2% operating margin, 19.3% ROIC, and recurring demand embedded in professional workflows, those are not demanding multiples. Even if you haircut growth to 5-6% revenue and assume limited margin expansion, you are still looking at a company converting roughly 84% of operating cash flow to free cash flow ($617.5M on $726.3M OCF) and earning well above its cost of capital. The balance sheet is also manageable rather than pristine: $1.37B debt against $337.7M cash is meaningful, but with $726M of operating cash generation it is not a strain. This looks like a durable quality compounder that has been derated into a more ordinary multiple.
The one real blemish in the raw numbers is margins. Annual operating income improved from $706.0M to $748.3M in 2025, but recent quarterly net margins have come off materially from the 25-26% range through most of fiscal 2025 to 21.8% and then 20.3% in the last two quarters. On the quarterly run-rate, net income of $126.7M on $622.9M revenue is a clear deterioration versus $148.5M on $585.5M a year earlier despite higher sales. That deserves attention because a low-growth information-services company depends on margin stability to justify a premium. But I read this as pressure on a still-elite margin structure, not an impairment of the model. The business can absorb some reinvestment or pricing friction and still produce returns most companies would envy.
The best argument against my read is that the market is correctly discounting a business whose best days are behind it. Revenue growth has moderated into the 5% range, free cash flow growth over the longer window is far weaker than earnings growth, and recent profits are moving the wrong way despite higher revenue. If AI lowers search, summarization, and modeling frictions across financial workflows, part of FactSet’s value proposition could be commoditized faster than its current customer stickiness suggests. Add formidable competitors with broader ecosystems, and the bear case is that today’s 18x earnings multiple is not cheap for a company that may be heading toward low-single-digit growth with mild margin compression. If the latest quarter’s 20.3% net margin is closer to the new normal than a temporary dip, then the apparent discount is smaller than it looks.
What would change my mind is straightforward. If quarterly revenue falls below a 4-5% year-over-year growth band while net margin stays around 20-22%, I would stop treating this as an underappreciated compounder and view it as a no-growth utility that deserves closer to 14-16x earnings. Likewise, if free cash flow drops materially below $600M despite revenue growth, the quality case weakens. On the other hand, if FactSet can show revenue sustaining above $620M-$630M quarterly with margins recovering back toward 24-25%, the current price will look too low for the durability on offer.
Grok Reading
FactSet’s numbers describe a high-quality franchise that has already matured into low-single-digit growth territory and is now showing clear margin pressure. Annual revenue climbed from $1.59B in FY2021 to $2.32B in FY2025, a respectable mid-single-digit path that matches the 5.5% revenue CAGR and the latest 5.4% year-over-year print. Free cash flow of $617.5M on that base (roughly 27% of sales, after only $109M of capex) and a 27% ROE / 19% ROIC confirm the business still converts subscriptions into cash at an elite rate. Yet the quarterly sequence tells a sharper story: revenue rose from $585.5M to $622.9M year-over-year, while net income fell from $148.5M to $126.7M and net margin compressed from the mid-25% range that prevailed for six straight quarters down to 20.3%. Operating leverage that previously lifted earnings CAGR to 12.9% has flipped; the most recent two quarters are delivering higher sales and lower profits. At 18.2× trailing earnings, 4.7× sales and 12.2× EV/EBITDA, the market is already pricing a mid-single-digit grower with a durable moat, not a re-acceleration story. The 6.1% FCF yield looks attractive on paper, but FCF itself has compounded at only 2.8%, so the cash-generation edge is less dynamic than the earnings history suggests.
The balance sheet is serviceable rather than fortress-like—$1.37B of debt against $338M cash and $2.19B of equity leaves a 0.63 debt-to-equity ratio and a current ratio of 1.4—while the 1.6% dividend (27% payout) is comfortably covered. Nothing here is broken; the franchise remains sticky and highly profitable on an annual basis (53% gross, 32% operating, 26% net). What stands out is the absence of any acceleration and the sudden appearance of cost pressure exactly when competitive and AI narratives are loudest. The stock’s roughly 27% drawdown from its 52-week high has simply brought the multiple into line with a 5% grower whose incremental margins are no longer expanding.
The strongest counter-argument is that the recent margin dip is temporary investment (AI productization, sales capacity, or mix) and that the underlying 27% ROE, $617M of annual FCF, and high switching costs still justify a re-rating toward the $310–316 composite fair-value range, implying 10–12% upside. A bull would also note that private-markets data and workflow upsell remain early, that the 18× P/E sits below the broader market, and that sell-side models still treat the moat as under-appreciated. I weigh those points less heavily because the earnings decline is already visible in two consecutive quarters, FCF growth has lagged for years, and the competitive set (Bloomberg, LSEG/Refinitiv) is not standing still on generative AI. Paying 18× for mid-single-digit revenue growth and currently shrinking net income is not a bargain; it is roughly fair compensation for quality that is no longer compounding as it once did.
I would reverse to a clear undervalued stance if the next two quarters restore net margins above 24% while organic revenue holds at or above 6%, or if management demonstrates measurable AI-driven ASP expansion that lifts FCF growth back into the high single digits. A break below $250 on further margin erosion or an explicit slowdown below 4% revenue growth would push me firmly into overvalued territory.
Qwen Reading local experiment · off-panel
The number that should be keeping every FactSet holder up at night is not the 18.2x P/E or the 4.69x P/S — it's the net margin. Five quarters ago, FactSet was converting 25.4% of revenue to net income. Two quarters ago, that number was 20.3%. Revenue grew 6.4% year-over-year in the May 2026 quarter to $622.9M, but net income fell from $148.5M to $126.7M, a 14.7% decline. That is not a rounding error or a one-time charge; it is a 500-basis-point margin compression in two consecutive quarters, and it is the single most important data point in this entire briefing. The prior models' "mature compounder" framing and the valuation synthesis's $310–$316 fair value range are built on the assumption that the 25.7% annual net margin (FY2025) is the steady-state. The quarterly data says it is not. If the 20–22% range is the new normal, forward earnings are closer to $500M than the $597M the trailing annual figure implies, which pushes the effective P/E toward 20x on a 6% grower. That is not a discount.
What I find genuinely impressive, and what the bear case undersells, is the cash flow. Operating cash flow of $726.3M against net income of $597.0M is a 1.22x conversion, and free cash flow of $617.5M on a $10.08B market cap is a 6.1% FCF yield. ROIC of 19.3% and ROE of 27.3% are elite for a company of this size, and the balance sheet, while carrying $1.37B in debt against $337.7M in cash, is manageable at 0.63x debt-to-equity with a 1.4x current ratio. The "earnings-to-cash-flow divergence" flagged by the Market Forces layer is, in my reading, overstated: the cash flow is *ahead* of earnings, not behind it. The margin compression is real, but it is not a profit-quality problem. It is a cost-structure problem, and those are different things. A company that generates $617M in FCF while its P&L margins wobble is not a broken business; it is a business in the middle of a cost transition, possibly absorbing AI investment, restructuring, or competitive pricing pressure.
The strongest case against my own read is the one the Market Forces layer makes: that the margin compression is not a transition but a structural erosion, and that the 5.5% revenue CAGR is the terminal rate, not a trough. A smart opponent would point to the fact that revenue growth has decelerated from the 10%+ pace of 2022–2023 to the 6–7% range of the last four quarters, that the FCF CAGR is a paltry 2.8%, and that Bloomberg's scale advantage in generative AI could compress FactSet's pricing power across the board. They would also note that the 2024 Q4 margin of 15.9% was not an outlier but a preview, and that the 25%+ margins of 2025 were the anomaly, not the norm. I weigh this differently because the annual operating margin has actually *expanded* from 32.2% in FY2025 to a trajectory that, even with the last two quarters' compression, still implies a full-year FY2026 operating margin in the low 30s. The gross margin of 52.7% is stable. The compression is below the gross line — in opex, in comp, in investment. That is a management choice, not a revenue-side collapse.
What would change my mind in either direction is specific and testable. If the August 2026 quarter (reporting around October 2026) shows net margin back above 24% and revenue growth reaccelerating to 8%+, the compression was a deliberate investment cycle and the $283 price is a genuine entry point with 10–15% upside. Conversely, if margin stays at or below 21% for a third consecutive quarter and revenue growth slips below 5%, the "mature compounder" thesis is dead and the stock should be trading at 14–15x forward earnings, which puts it in the $230–$250 range. The Bloomberg AI product roadmap and any concrete FactSet AI revenue disclosure on the next two earnings calls are the binary catalysts that will resolve which of those paths is real.
The valuation synthesis's +11.6% upside call treats the methods as if they are independent, but they are not — they all inherit the same terminal growth assumption and the same margin normalization. The "slight upside" verdict is a function of averaging a DCF that assumes 25% margins forward with a P/E multiple that already bakes in 25% margins. You cannot get upside from both. At 18.2x trailing earnings with margins in a 500-bps downtrend and revenue growth in the mid-single digits, the stock is not cheap. It is not expensive either, because the FCF yield and the ROIC are genuinely strong. It is a stock where the right price depends entirely on whether the margin compression is a dip or a step-change, and the data, as of this briefing, has not yet told you which.
Big-3 Panel — where each AI stands
Advanced Analysis Forensic deep-dive · separate lenses
Revenue grew from 1.59B in 2021 to 2.32B in 2025 (about 10% CAGR), with operating margin expanding from 29.8% to 32.2% and net income climbing from 400M to 597M. FCF rose from 494M to 618M, converting well above net income (OCF/NI 1.33x) and accruals are a clean -4.4% of assets. Beneish M at -2.39 and Altman Z at 4.78 corroborate that reported earnings are real cash economics, not accounting embellishment. Diluted share count actually shrank slightly (38.6M to 38.4M) with buyback/SBC coverage of 346%, so per-share value is protected rather than eroded. Gross margin dipped from 54.1% to 52.7% in the most recent year - a small wobble worth watching but not alarming given continued operating leverage. Net debt of about 1.0B against 618M annual FCF is a leash, not a threat: leverage is roughly 1.6x FCF and easily serviced. The business profile - recurring subscription financial data - is inherently sticky with high switching costs, and the mechanical trajectory (steady top-line growth, expanding margins, high cash conversion, buybacks) is what a well-run mature compounder looks like.
Verify before trusting this (5)
- Cause of 2025 GM% dip (140bps) - mix, AI/compute costs, or pricing concessions?
- Client retention / ASV growth disclosed in 10-K to confirm subscription stickiness
- Debt maturity schedule and covenants behind the ~1B net debt position
- Customer concentration among top clients (buy-side vs sell-side mix)
- Any pending goodwill or acquired-intangibles risk from the CUSIP Global Services acquisition
The e2e composite pins fair value at $310.88 (signal-adjusted $316.28) against a $283.49 price - roughly 10-12% upside, which is inside the noise band for a mature compounder. The DCF ($326.93) and anchored-PE ($397.53) skew bullish but the EPV floor at $192.13 is a loud reminder that if growth stalls, the no-growth earnings power sits ~32% BELOW today's price. That spread ($192 to $397) tells you the market is paying a fair premium for continued compounding, not a discount. Earnings quality is pristine (score 3), so no haircut is warranted, but the strong business grade is already reflected in the multiple - it does not create a gap. What is priced in: continued mid-single to low-double-digit revenue growth, stable ~35% operating margins, and no meaningful disruption from Bloomberg/cloud-native competitors on the AI front. That is plausible but not conservative. To call this cheap I would need the price closer to the midpoint of EPV and composite FV - roughly $240-$250 - which would give a real margin of safety against the deceleration/commoditization bear case. At $283 you are paying full freight for a strong business the market already understands.
Verify before trusting this (4)
- Organic ASV growth rate trajectory and client retention metrics in the next quarterly release
- Operating margin guidance and whether AI/R&D spend is compressing the 35%+ target
- Any commentary on price increases sticking vs client pushback
- Buyback pace vs SBC to confirm share count discipline continues
FDS sits in a quiet corner of the tape. The narrative here is a low-intensity, durable steady-compounder story with minimal cult premium - which means there is neither a hype wave lifting it nor a broken story crushing it. In a mildly risk-on regime (VIX 14, S&P near highs), a 0.69-beta financial-data name captures very little of the upside; low-beta compounders get left behind when animal spirits are on. That mutes any tailwind. On the other side, there is no visible negative catalyst - a routine dividend declaration is the only company-specific headline, and news flow is dominated by unrelated names. The bear whisper (cloud/AI commoditization of terminals, Bloomberg/Refinitiv AI competition) exists but is not currently being priced or amplified - it is a slow-burn concern, not an active de-rating. Analyst tone and target revisions are not flagged as directional. Net: this is a name the market is largely ignoring right now, which for a defensive compounder is closer to neutral than to headwind.
Verify before trusting this (4)
- Any sell-side note reframing FDS as an AI loser vs Bloomberg/Refinitiv
- Signs of institutional client seat cuts amid buyside layoffs (would activate the bear narrative)
- Sector rotation out of defensives if risk-on intensifies
- Next earnings ASV growth print - the key sentiment lever for this cohort
The world's demand for institutional financial data keeps rising, but the value is migrating to two poles: proprietary IP/index-and-ratings franchises and cheap programmatic data plumbing. FDS sits in the middle as a workflow integrator — a strong position while human analysts drive research, a contested one if AI agents become the consumer of data. Macro headwinds (10y 4.63, flat-ish curve) keep asset-manager fee pressure and headcount discipline in place, capping seat growth, while deal-making and private-markets recovery would help the newer adjacencies. Net: a steady, defensible, slow-compounding business in a category that grows a bit faster than it does.